Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations
Titel:
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations
Auteur:
Farina, Gabriella Longo, Flavia Martelli, Olga Pavese, Ida Mancuso, Andrea Moscetti, Luca Labianca, Roberto Bertolini, Alessandro Cortesi, Enrico Farris, Antonio Fagnani, Daniele Locatelli, Maria Cristina Valmadre, Giuseppe Ardizzoia, Antonio Tomirotti, Maurizio Rulli, Eliana Garassino, Marina Chiara Scanni, Alberto